Literature DB >> 31422872

Are Lifestyle Therapies Effective for NAFLD Treatment?

Nermeen N El-Agroudy1, Anica Kurzbach1, Roman N Rodionov2, John O'Sullivan3, Michael Roden4, Andreas L Birkenfeld5, Dominik H Pesta6.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is becoming the most common liver disorder worldwide. Specifically, nonalcoholic steatohepatitis (NASH) and fibrosis pose an enormous burden for patients and health-care systems. In the absence of approved pharmacological therapies, effective lifestyle interventions for NAFLD, such as dietary strategies and exercise training, are currently the therapeutic strategies of choice. This review covers the influence of macronutrient quality and quantity (i.e., low-carbohydrate and high-protein diets), for successful reduction of intrahepatocellular lipids (IHL). Moreover, we discuss the effectiveness of different modalities of physical exercising with and without weight loss. These lifestyle modifications not only provide strategies to reduce IHL but may also hold a still underestimated potential to induce improvement and/or even remission of NAFLD.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  NAFLD; exercise; lifestyle modification; nutrition; physical activity; weight loss

Mesh:

Year:  2019        PMID: 31422872     DOI: 10.1016/j.tem.2019.07.013

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  27 in total

1.  The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults.

Authors:  Ehsaneh Taheri; Mohammad Amin Pourhoseingholi; Alireza Moslem; Amir Hossein Hassani; Alireza Mousavi Jarrahi; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali; Behzad Hatami
Journal:  J Diabetes Metab Disord       Date:  2022-01-11

2.  A randomized, placebo-controlled clinical trial of hydrogen/oxygen inhalation for non-alcoholic fatty liver disease.

Authors:  Geru Tao; Guangjie Zhang; Wei Chen; Chao Yang; Yazhuo Xue; Guohua Song; Shucun Qin
Journal:  J Cell Mol Med       Date:  2022-06-23       Impact factor: 5.295

Review 3.  NAFLD: Mechanisms, Treatments, and Biomarkers.

Authors:  Fatiha Nassir
Journal:  Biomolecules       Date:  2022-06-13

4.  Consumption of Low Dose Fucoxanthin Does Not Prevent Hepatic and Adipose Inflammation and Fibrosis in Mouse Models of Diet-Induced Obesity.

Authors:  Mi-Bo Kim; Minkyung Bae; Yoojin Lee; Hyunju Kang; Siqi Hu; Tho X Pham; Young-Ki Park; Ji-Young Lee
Journal:  Nutrients       Date:  2022-05-29       Impact factor: 6.706

Review 5.  Why are South Asians prone to type 2 diabetes? A hypothesis based on underexplored pathways.

Authors:  K M Venkat Narayan; Alka M Kanaya
Journal:  Diabetologia       Date:  2020-03-31       Impact factor: 10.122

Review 6.  Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents.

Authors:  Farah D R Al-Baiaty; Aziana Ismail; Zarina Abdul Latiff; Khairul Najmi Muhammad Nawawi; Raja Affendi Raja Ali; Norfilza Mohd Mokhtar
Journal:  Front Pediatr       Date:  2021-07-08       Impact factor: 3.418

7.  ChREBP-driven DNL and PNPLA3 Expression Induced by Liquid Fructose are Essential in the Production of Fatty Liver and Hypertriglyceridemia in a High-Fat Diet-Fed Rat Model.

Authors:  Ana Magdalena Velázquez; Roger Bentanachs; Aleix Sala-Vila; Iolanda Lázaro; Jose Rodríguez-Morató; Rosa M Sánchez; Marta Alegret; Núria Roglans; Juan Carlos Laguna
Journal:  Mol Nutr Food Res       Date:  2022-02-15       Impact factor: 6.575

8.  Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population.

Authors:  Xinting Pan; Xiaoxu Xie; Hewei Peng; Xiaoling Cai; Huiquan Li; Qizhu Hong; Yunli Wu; Xu Lin; Shanghua Xu; Xian-E Peng
Journal:  Front Public Health       Date:  2020-07-02

9.  Fasting Glucose State Determines Metabolic Response to Supplementation with Insoluble Cereal Fibre: A Secondary Analysis of the Optimal Fibre Trial (OptiFiT).

Authors:  Stefan Kabisch; Nina M T Meyer; Caroline Honsek; Christiana Gerbracht; Ulrike Dambeck; Margrit Kemper; Martin A Osterhoff; Andreas L Birkenfeld; Ayman M Arafat; Mads F Hjorth; Martin O Weickert; Andreas F H Pfeiffer
Journal:  Nutrients       Date:  2019-10-06       Impact factor: 5.717

10.  The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Ewa Stachowska; Piero Portincasa; Dominika Jamioł-Milc; Dominika Maciejewska-Markiewicz; Karolina Skonieczna-Żydecka
Journal:  Nutrients       Date:  2020-11-11       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.